Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-05 4:31 pm Purchase | 2022-12-01 | 13D | Rocket Pharmaceuticals, Inc. RCKT | RTW Investments, LP | 18,188,457 23.000% | 559,890 (+3.18%) | Filing History |
| 2023-02-14 10:29 am Sale | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 0 0.000% | -253,735 (Position Closed) | Filing History |
| 2023-02-14 10:27 am Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW Investments, LP | 0 0.000% | -190,656 (Position Closed) | Filing History |
| 2023-02-14 10:24 am Sale | 2022-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN | RTW Investments, LP | 0 0.000% | -406,250 (Position Closed) | Filing History |
| 2023-02-14 10:22 am Sale | 2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | RTW Investments, LP | 0 0.000% | -6,029,700 (Position Closed) | Filing History |
| 2023-02-14 10:20 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RTW Investments, LP | 0 0.000% | -755,482 (Position Closed) | Filing History |
| 2023-02-14 10:17 am Sale | 2022-12-31 | 13G | BELLUS Health Inc. BLU | RTW Investments, LP | 0 0.000% | -5,968,017 (Position Closed) | Filing History |
| 2023-02-14 10:15 am Sale | 2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RTW Investments, LP | 0 0.000% | -0 (Position Closed) | Filing History |
| 2023-02-14 10:13 am Sale | 2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 0 0.000% | -7,027,725 (Position Closed) | Filing History |
| 2023-02-14 10:12 am Sale | 2022-12-31 | 13G | MacroGenics, Inc. MGNX | RTW Investments, LP | 0 0.000% | -3,975,554 (Position Closed) | Filing History |
| 2023-02-14 10:11 am Sale | 2022-12-31 | 13G | Vericel Corporation VCEL | RTW Investments, LP | 3,099,904 6.600% | -1,417,666 (-31.38%) | Filing History |
| 2023-02-14 10:11 am Sale | 2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | RTW Investments, LP | 0 0.000% | -2,520,076 (Position Closed) | Filing History |
| 2023-02-14 10:10 am Purchase | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW Investments, LP | 3,966,915 5.700% | 3,966,915 (New Position) | Filing History |
| 2023-02-14 10:10 am Sale | 2022-12-31 | 13G | TELA Bio, Inc. TELA | RTW Investments, LP | 390,364 2.000% | -1,009,322 (-72.11%) | Filing History |
| 2023-02-14 10:10 am Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW Investments, LP | 2,067,824 6.900% | -118,500 (-5.42%) | Filing History |
| 2023-02-14 10:09 am Purchase | 2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | RTW Investments, LP | 3,643,114 6.300% | 3,643,114 (New Position) | Filing History |
| 2023-02-14 10:09 am Purchase | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 2,548,125 9.600% | 534,524 (+26.55%) | Filing History |
| 2023-02-14 10:08 am Sale | 2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RTW Investments, LP | 3,084,215 6.500% | -837,364 (-21.35%) | Filing History |
| 2023-02-14 10:08 am Purchase | 2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 3,870,981 9.800% | 226,733 (+6.22%) | Filing History |
| 2023-02-14 10:08 am Purchase | 2022-12-31 | 13G | C4 Therapeutics, Inc. CCCC | RTW Investments, LP | 2,819,472 5.800% | 324,507 (+13.01%) | Filing History |